Items where authors include "Oladipo, O."
![[up]](/style/images/multi_up.png)
Up a levelJump to: Conference abstract
Number of items: 2.
Conference abstract
Gkountouras, G. orcid.org/0000-0003-2093-5359, Meads, D., Mujica-Mota, R. et al. (16 more authors) (2025) LBA2 The DANTE phase III trial comparing 1 year versus 2 years of anti-PD1 immunotherapy as first-line treatment for metastatic melanoma: Health economics analysis. [Conference abstract]
Danson, S., Collinson, M., Plummer, E.R. et al. (17 more authors) (2025) Comparison of 1 year versus minimum 2 years of anti-PD1-based immunotherapy as first-line treatment for metastatic melanoma: Results of the DANTE phase III trial. [Conference abstract]